FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...
Enzymes are the molecular machines that power life; they build and break down molecules, copy DNA, digest food, and drive ...
First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in budoprutug Phase 1b/2a trial in ITP and Phase 1b trial in SLE; achieved ...
First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...
“We found that gut bacteria, including Escherichia coli and Klebsiella pneumoniae, ferment sugars into ethanol in the ...
Ectopic pregnancies are rare but very serious, and you may not hear about them until you (or someone you know) experience one.
Another common reason for nosebleeds is “digital manipulation, which is a nice way of saying nose picking or scratching your ...